EP 2775835 A4 20150729 - METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS
Title (en)
METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS
Title (de)
VERFAHREN ZUR BEHANDLUNG VON GICHT BEI EINER PATIENTENUNTERGRUPPE
Title (fr)
PROCÉDÉS PERMETTANT DE TRAITER LA GOUTTE CHEZ DES GROUPES DE PATIENTS
Publication
Application
Priority
US 2011059425 W 20111104
Abstract (en)
[origin: WO2013066352A1] In one embodiment, the present application discloses a method of lowering serum uric acid level in a subject with impaired renal function, comprising administering to the subject a compound of Formula (I), as disclosed herein.
IPC 8 full level
A61K 31/20 (2006.01); A01N 37/00 (2006.01); A61P 19/06 (2006.01)
CPC (source: EP)
A61K 31/216 (2013.01); A61P 7/00 (2017.12); A61P 13/00 (2017.12); A61P 13/12 (2017.12); A61P 19/06 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [Y] US 6613802 B1 20030902 - LUSKEY KENNETH L [US], et al
- [Y] US 4250191 A 19810210 - EDWARDS K DAVID [US]
- [Y] US 6262118 B1 20010717 - LUSKEY KENNETH L [US], et al
- [XY] ANONYMOUS: "Metabolex Initiates Phase 2 Trial of Arhalofenate", 19 May 2011 (2011-05-19), XP002740529, Retrieved from the Internet <URL:http://www.prnewswire.com/news-releases> [retrieved on 20150603]
- [XY] ANONYMOUS: "Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer", 20 October 2011 (2011-10-20), XP002740530, Retrieved from the Internet <URL:http://www.fiercebiotech.com> [retrieved on 20150603]
- [Y] EL-ZAWAWY HOSSAM ET AL: "Managing gout: How is it different in patients with chronic kidney disease?", CLEVELAND CLINIC JOURNAL OF MEDICINE, vol. 77, no. 12, December 2010 (2010-12-01), pages 919 - 928, XP002740531
- [Y] MAHESH J FULDEORE ET AL: "Chronic kidney disease in gout in a managed care setting", BMC NEPHROLOGY, BIOMED CENTRAL, LONDON, GB, vol. 12, no. 1, 3 August 2011 (2011-08-03), pages 36, XP021108842, ISSN: 1471-2369, DOI: 10.1186/1471-2369-12-36
- [Y] EDWARDS K D G ET AL: "AMINO NUCLEOSIDE INDUCED CHRONIC RENAL FAILURE IN RATS ENHANCEMENT BY DIETARY HYPER LIPIDEMIAS AND PROTECTION BY A HYPO LIPIDEMIC DIET OR HALOFENATE", KIDNEY INTERNATIONAL, vol. 14, no. 6, 1978, pages 723, XP002740532, ISSN: 0085-2538
- [Y] EDWARDS K D G ET AL: "PROTECTION BY L TRYPTOPHAN OR HALOFENATE AGAINST HYPER LIPIDEMIA AND ACUTE OR CHRONIC AMINO NUCLEOSIDE NEPHROSIS IN SUCROSE LARD FED RATS", KIDNEY INTERNATIONAL, vol. 12, no. 6, 1977, pages 480, XP002740533, ISSN: 0085-2538
- See references of WO 2013066352A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013066352 A1 20130510; AU 2011380509 A1 20140529; AU 2011380509 B2 20160519; BR 112014010693 A2 20201110; CA 2859689 A1 20130510; CA 2859689 C 20180522; CL 2014001156 A1 20150116; CN 104066323 A 20140924; EP 2775835 A1 20140917; EP 2775835 A4 20150729; IL 232385 A0 20140630; IL 232385 A 20171031; JP 2014532759 A 20141208; JP 6047172 B2 20161221; KR 101848122 B1 20180411; KR 20140123927 A 20141023; MX 2014005399 A 20150408; MX 354846 B 20180322; NZ 624714 A 20160129; SG 11201402027P A 20140926; ZA 201403574 B 20151125
DOCDB simple family (application)
US 2011059425 W 20111104; AU 2011380509 A 20111104; BR 112014010693 A 20111104; CA 2859689 A 20111104; CL 2014001156 A 20140502; CN 201180076189 A 20111104; EP 11875027 A 20111104; IL 23238514 A 20140430; JP 2014541012 A 20111104; KR 20147015209 A 20111104; MX 2014005399 A 20111104; NZ 62471411 A 20111104; SG 11201402027P A 20111104; ZA 201403574 A 20140516